Anika Therapeutics Inc.Anika Therapeutics Inc.Anika Therapeutics Inc.

Anika Therapeutics Inc.

No trades
See on Supercharts
Market capitalization
‪366.02 M‬USD
−5.64USD
‪−82.67 M‬USD
‪166.66 M‬USD
‪14.16 M‬
Beta (1Y)
0.84

About Anika Therapeutics Inc.

CEO
Cheryl Renee Blanchard
Headquarters
Bedford
Employees (FY)
357
Founded
1992
ISIN
US0352551081
FIGI
BBG000BBKZD8
Anika Therapeutics, Inc. is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. Its products are based on hyaluronic acid, a natural chemical occurring, biocompatible polymer found throughout the body. It offers therapeutic products which include orthobiologics, dermal, ophthalmic, surgical, ophthalmic and veterinary. The company's main focus is on high opportunity spaces within orthopedics, including Osteoarthritis Pain Management, Regenerative Solutions, Sports Medicine and Arthrosurface Joint Solutions, and its products are efficiently delivered in key sites of care, including ambulatory surgery centers. Anika Therapeutics was founded in 1992 and is headquartered in Bedford, MA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of ANIK is 25.51 USD — it has increased by 0.79% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Anika Therapeutics Inc. stocks are traded under the ticker ANIK.
Anika Therapeutics Inc. is going to release the next earnings report on May 2, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for Anika Therapeutics Inc. has a max estimate of 37.00 USD and a min estimate of 22.00 USD.
Anika Therapeutics Inc. revenue for the last quarter amounts to ‪41.47 M‬ USD despite the estimated figure of ‪38.27 M‬ USD. In the next quarter revenue is expected to reach ‪41.40 M‬ USD.
Yes, you can track Anika Therapeutics Inc. financials in yearly and quarterly reports right on TradingView.
Like other stocks, ANIK shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Anika Therapeutics Inc. stock right from TradingView charts — choose your broker and connect to your account.
ANIK reached its all-time high on Oct 25, 2019 with the price of 75.72 USD, and its all-time low was 0.69 USD and was reached on Dec 29, 2000.
See other stocks reaching their highest and lowest prices.
As of Apr 16, 2024, the company has 357.00 employees. See our rating of the largest employees — is Anika Therapeutics Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Anika Therapeutics Inc. EBITDA is ‪−9.62 M‬ USD, and current EBITDA margin is 1.07%. See more stats in Anika Therapeutics Inc. financial statements.